Whalesbook
Financial Performance Soars, Global Ambitions Take Flight
Anupam Rasayan India Limited (ARIL) has unveiled robust financial results for its third quarter of fiscal year 2026 (Q3 FY26), reporting a significant 31% year-on-year (YoY) increase in revenue, reaching ₹512 crore. This surge highlights the company's accelerating growth trajectory. For the nine-month period ending December 31, 2025 (9MFY26), revenue climbed an impressive 84% YoY to ₹1,730 crore. Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA), a measure of operational profitability, grew 12% YoY to ₹130 crore in Q3, with an EBITDA margin holding steady at a healthy 25%. Profit After Tax (PAT) for the quarter stood at ₹61 crore. The 9MFY26 EBITDA grew 53% YoY to ₹402 crore, with PAT seeing a 71% YoY rise to ₹166 crore, indicating strong bottom-line expansion across the year.
Strategic Leap with US Acquisition
Adding significant strategic weight to its financial performance, Anupam Rasayan announced it has signed a definitive agreement to acquire 100% of US-based specialty chemicals company Jayhawk Fine Chemicals. This move is poised to be earnings-per-share (EPS) accretive from day one. The acquisition aims to establish a direct manufacturing presence in the United States, fortify its local supply chain for North American clients, and unlock access to high-growth sectors like semiconductor, aerospace, pharmaceuticals, electric vehicles, and electronics. This global expansion complements ARIL's existing backward integration strategy, particularly its increased stake in Tanfac, acquired in 2022, which secures critical raw materials such as Hydrogen Fluoride (HF) and Potassium Fluoride (KF) for its fluorination chemistry capabilities.
Growth Drivers and Future Focus
Management attributed the revenue growth to the successful scaling-up of commercial molecules, improved asset utilization, and strong execution across its order book, particularly in the Agro and Performance Material segments. The Pharma segment showed remarkable 85% YoY growth in 9MFY26, contributing 19% to the total revenue. The Polymer and Performance Material segments experienced an explosive 245% YoY growth in 9MFY26. Exports constitute a significant 58% of ARIL's total revenue. A key focus for the company is reducing its working capital intensity, which currently stands around 250 days, with a target to bring it down to below 200 days by FY27. The company is also concentrating on expanding its fluorination chemistry expertise and bolstering its Pharma and Performance Material portfolios.
Outlook
Looking ahead, Anupam Rasayan's management expressed optimism, anticipating continued growth momentum fueled by strong pipeline visibility, deeper customer relationships, and the strategic global footprint expansion facilitated by the Jayhawk acquisition. The company is evolving into a global specialty chemical platform, set to serve key geographies and high-growth industries.
Peer Comparison
In the competitive Indian specialty chemicals landscape, Anupam Rasayan's aggressive growth, particularly driven by its Pharma and Performance Material segments, positions it strongly. Competitors like Aarti Industries and Vinati Organics have also been focused on expanding capacities and product portfolios. Navin Fluorine International, a direct player in fluorination chemistry, is another key rival. While specific recent performance data for peers wasn't detailed, ARIL's proactive US expansion through Jayhawk signifies a strategic move to diversify geographically and tap into markets where many Indian chemical firms are increasingly seeking a manufacturing foothold. The emphasis on complex chemistry and high-value end-markets aligns with the sector's overall trend towards specialized, high-margin products. ARIL's strong revenue growth, especially in its specialized segments, suggests it is capturing market share and capitalizing on global demand for advanced chemical intermediates.